CD68 and hepatocellular carcinoma: In the present study, we showed that CD68+ myeloid cells were the major PD-L1+ immune cells in HCC (61.29 ± 3.84 % of total PD-L1+ cells), and were further used to divide the samples into four groups with different PD-L1 expression patterns.